GENTAMICIN SULFATE (GENTAMICIN SULFATE) — FDA Approval ANDA062356 (FRESENIUS KABI USA)
GENTAMICIN SULFATE (GENTAMICIN SULFATE) — FDA Approval ANDA062356 (FRESENIUS KABI USA) is one of 9,000 drug approvals in the DrugApprovals dataset. Key details — Brand name: GENTAMICIN SULFATE; Active ingredients: GENTAMICIN SULFATE; Application number: ANDA062356.
| Brand name | GENTAMICIN SULFATE |
|---|---|
| Active ingredients | GENTAMICIN SULFATE |
| Application number | ANDA062356 |
| Sponsor | FRESENIUS KABI USA |
| Dosage form | INJECTABLE |
| Route | INJECTION |
| Marketing status | Discontinued |
| Products in application | 2 |
| First approval date | 19820304 |
| Source | openFDA Drugs@FDA |
$1499/mo
Try DrugApprovals →